19-51716766-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001297436.2(HAS1):​c.925+202G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 151,560 control chromosomes in the GnomAD database, including 34,854 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 34854 hom., cov: 29)

Consequence

HAS1
NM_001297436.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0290

Publications

7 publications found
Variant links:
Genes affected
HAS1 (HGNC:4818): (hyaluronan synthase 1) Hyaluronan or hyaluronic acid (HA) is a high molecular weight unbranched polysaccharide synthesized by a wide variety of organisms from bacteria to mammals, and is a constituent of the extracellular matrix. It consists of alternating glucuronic acid and N-acetylglucosamine residues that are linked by beta-1-3 and beta-1-4 glycosidic bonds. HA is synthesized by membrane-bound synthase at the inner surface of the plasma membrane, and the chains are extruded through pore-like structures into the extracellular space. It serves a variety of functions, including space filling, lubrication of joints, and provision of a matrix through which cells can migrate. HA is actively produced during wound healing and tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts. Changes in the serum concentration of HA are associated with inflammatory and degenerative arthropathies such as rheumatoid arthritis. In addition, the interaction of HA with the leukocyte receptor CD44 is important in tissue-specific homing by leukocytes, and overexpression of HA receptors has been correlated with tumor metastasis. HAS1 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to the hasA gene product of Streptococcus pyogenes, a glycosaminoglycan synthetase (DG42) from Xenopus laevis, and a recently described murine hyaluronan synthase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.851 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001297436.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS1
NM_001297436.2
MANE Select
c.925+202G>A
intron
N/ANP_001284365.1G3V1S7
HAS1
NM_001523.4
c.928+202G>A
intron
N/ANP_001514.2Q92839

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS1
ENST00000540069.7
TSL:1 MANE Select
c.925+202G>A
intron
N/AENSP00000445021.2G3V1S7
HAS1
ENST00000601714.5
TSL:1
c.949+202G>A
intron
N/AENSP00000472821.1M0R2V0
HAS1
ENST00000222115.5
TSL:1
c.928+202G>A
intron
N/AENSP00000222115.1Q92839

Frequencies

GnomAD3 genomes
AF:
0.670
AC:
101433
AN:
151442
Hom.:
34823
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.521
Gnomad AMI
AF:
0.571
Gnomad AMR
AF:
0.749
Gnomad ASJ
AF:
0.693
Gnomad EAS
AF:
0.872
Gnomad SAS
AF:
0.754
Gnomad FIN
AF:
0.798
Gnomad MID
AF:
0.680
Gnomad NFE
AF:
0.702
Gnomad OTH
AF:
0.652
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.670
AC:
101518
AN:
151560
Hom.:
34854
Cov.:
29
AF XY:
0.678
AC XY:
50184
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.521
AC:
21480
AN:
41234
American (AMR)
AF:
0.750
AC:
11402
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
2402
AN:
3466
East Asian (EAS)
AF:
0.873
AC:
4479
AN:
5132
South Asian (SAS)
AF:
0.754
AC:
3625
AN:
4810
European-Finnish (FIN)
AF:
0.798
AC:
8396
AN:
10522
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.702
AC:
47635
AN:
67884
Other (OTH)
AF:
0.655
AC:
1375
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1625
3249
4874
6498
8123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.690
Hom.:
139728
Bravo
AF:
0.655
Asia WGS
AF:
0.801
AC:
2780
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.5
DANN
Benign
0.61
PhyloP100
0.029
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11084109; hg19: chr19-52220019; API